Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | HemaSphere |
| Online Access: | https://doi.org/10.1002/hem3.70080 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850202515568590848 |
|---|---|
| author | Alexandra Albertsson‐Lindblad Sara Ekberg Ingrid Glimelius Fredrik Ellin Kristina Sonnevi Catharina Lewerin Lena Brandefors Karin E. Smedby Mats Jerkeman |
| author_facet | Alexandra Albertsson‐Lindblad Sara Ekberg Ingrid Glimelius Fredrik Ellin Kristina Sonnevi Catharina Lewerin Lena Brandefors Karin E. Smedby Mats Jerkeman |
| author_sort | Alexandra Albertsson‐Lindblad |
| collection | DOAJ |
| format | Article |
| id | doaj-art-db6f006b5e7b456995ed1d8528da405d |
| institution | OA Journals |
| issn | 2572-9241 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj-art-db6f006b5e7b456995ed1d8528da405d2025-08-20T02:11:46ZengWileyHemaSphere2572-92412025-01-0191n/an/a10.1002/hem3.70080Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018Alexandra Albertsson‐Lindblad0Sara Ekberg1Ingrid Glimelius2Fredrik Ellin3Kristina Sonnevi4Catharina Lewerin5Lena Brandefors6Karin E. Smedby7Mats Jerkeman8Department of Clinical Sciences Lund, Division of Oncology Skåne University Hospital Lund University Lund SwedenDepartment of Medicine Solna, Clinical Epidemiology Division Karolinska Institutet Stockholm SwedenDepartment of Immunology, Genetics and Pathology Cancer Precision Medicine Uppsala University Uppsala SwedenDepartment of Internal Medicine Kalmar Hospital Kalmar SwedenDepartment of Medicine Huddinge Karolinska Institute Stockholm SwedenDepartment of Hematology and Coagulation Sahlgrenska University Hospital University of Gothenburg Gothenburg SwedenDepartment of Internal Medicine Sunderbyn Hospital Luleå SwedenDepartment of Medicine Solna, Clinical Epidemiology Division Karolinska Institutet Stockholm SwedenDepartment of Clinical Sciences Lund, Division of Oncology Skåne University Hospital Lund University Lund Swedenhttps://doi.org/10.1002/hem3.70080 |
| spellingShingle | Alexandra Albertsson‐Lindblad Sara Ekberg Ingrid Glimelius Fredrik Ellin Kristina Sonnevi Catharina Lewerin Lena Brandefors Karin E. Smedby Mats Jerkeman Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018 HemaSphere |
| title | Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018 |
| title_full | Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018 |
| title_fullStr | Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018 |
| title_full_unstemmed | Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018 |
| title_short | Limited stage mantle cell lymphoma: A real‐world study of primary treatment and prognosis in Sweden 2006–2018 |
| title_sort | limited stage mantle cell lymphoma a real world study of primary treatment and prognosis in sweden 2006 2018 |
| url | https://doi.org/10.1002/hem3.70080 |
| work_keys_str_mv | AT alexandraalbertssonlindblad limitedstagemantlecelllymphomaarealworldstudyofprimarytreatmentandprognosisinsweden20062018 AT saraekberg limitedstagemantlecelllymphomaarealworldstudyofprimarytreatmentandprognosisinsweden20062018 AT ingridglimelius limitedstagemantlecelllymphomaarealworldstudyofprimarytreatmentandprognosisinsweden20062018 AT fredrikellin limitedstagemantlecelllymphomaarealworldstudyofprimarytreatmentandprognosisinsweden20062018 AT kristinasonnevi limitedstagemantlecelllymphomaarealworldstudyofprimarytreatmentandprognosisinsweden20062018 AT catharinalewerin limitedstagemantlecelllymphomaarealworldstudyofprimarytreatmentandprognosisinsweden20062018 AT lenabrandefors limitedstagemantlecelllymphomaarealworldstudyofprimarytreatmentandprognosisinsweden20062018 AT karinesmedby limitedstagemantlecelllymphomaarealworldstudyofprimarytreatmentandprognosisinsweden20062018 AT matsjerkeman limitedstagemantlecelllymphomaarealworldstudyofprimarytreatmentandprognosisinsweden20062018 |